McDavid Stilwell

McDavid Stilwell is a seasoned financial executive with extensive experience in various leadership roles across the biotechnology and financial sectors. Currently serving as Chief Financial Officer at CPTx since February 2025, McDavid previously held the position of Interim Chief Financial Officer at iCell Gene Therapeutics and Chief Financial Officer at Coherus Oncology, where responsibilities expanded to include Executive Vice President duties. Previous roles include Senior Vice President of Communications & Investor Relations at Sangamo Therapeutics, Vice President at Orexigen Therapeutics, and Director of Corporate Communications at GTx, Inc. McDavid began a finance career as a Senior Analyst at Shadwell Capital after obtaining an MBA from Harvard Business School and a BA in Philosophy and Mathematics from St. John's College.